Please use this identifier to cite or link to this item:
http://10.1.7.192:80/jspui/handle/123456789/12158
Title: | Regulatory Requirement and Re-Registration of Pharmaceutical Products in the Republic of Moldova |
Authors: | Patel, Yesha |
Keywords: | Dissertation Report Regulatory Affairs 22MPH 22MPH812 PDR00850 |
Issue Date: | May-2024 |
Publisher: | Institute of Pharmacy, Nirma University, A'bad |
Series/Report no.: | PDR00850; |
Abstract: | Regulatory compliance of food and nutraceutical industries in the United States is a complex landscape that is covered in this comprehensive guide. Businesses need to understand and navigate these regulations, which are crucial for them to thrive in the face of stiff competition. The Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) act as leading regulatory bodies overseeing safety, accuracy of labeling, and manufacturing practices. Such key laws include the Federal Food, Drug, and Cosmetic Act (FD&C Act), the Food Safety Modernization Act (FSMA), as well as the Dietary Supplement Health and Education Act (DSHEA). FSMA enacted in 2011 emphasizes preventive controls to mitigate outbreaks of foodborne illnesses while DSHEA enacted back in 1994 created a regulatory category for dietary supplements including labeling, safety requirements, as well as manufacturing. The businesses have challenges with keeping up with ever changing regulations; managing a global supply chain; being transparent with label provisions and marketing; despite of having laws at place that would be anticipated to help them achieve this. Robust quality management systems; fostering culture of compliance; working together with regulatory experts, leveraging technology solutions are some ways companies can effectively navigate through compliance. Through proactive strategies like best practices coupled by adoption of best practices among others firms can make sure consumers’ security is not compromised hence they can still remain relevant within market accessibility even when there are several obstacles presented by intricate regulations or industrial dynamics. |
URI: | http://10.1.7.192:80/jspui/handle/123456789/12158 |
Appears in Collections: | M.Pharm. Research Reports, Pharmaceutical Analysis |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PDR00850_22MPH812.pdf | PDR00850 | 5.77 MB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.